Mammographic screening after the age of 65 years: Evidence for a reduction in breast cancer mortality

International Journal of Cancer

Volumn 66, Issue 6, 1996, Pages 727-731

  Van Dijk, Jos A A M ^a,d   Verbeek, André L M ^a   Beex, Louk V A M ^a   Hendriks, Jan H C L ^a   Holland, Roland ^a   Mravunac, Marcel ^b   Straatman, Huub ^a   Werre, Jan M ^c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^c CENTRAL LABORATORY   (Netherlands)

^d RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NETHERLANDS; PRIORITY JOURNAL;

AGED; BIAS (EPIDEMIOLOGY); BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INCIDENCE; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NETHERLANDS; PROGRAM EVALUATION; RETROSPECTIVE STUDIES;

EID: 0029893445     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960611)66:6<727::AID-IJC3>3.0.CO;2-1     Document Type: Article

References (32)

1. BEEN, L.V.A.M. and WOBBES, T., Breast cancer in the elderly, prognosis and treatment (in Dutch). Tijdschr. Gerontol. Geriatr., 17, 59-63 (1986).
2. BERGMAN, L., KLUCK, H.M., VAN LEEUWEN, F.E., CROMMELIN, M.A., DEKKER, G., HART, A.A.M. and COEBERGH, J.W.W., The influence of age on treatment choice and survival of elderly breast cancer patients in South-eastern Netherlands: a population-based study. Europ. J. Cancer, 28A, 1475-1480 (1992).
3. BROWN, J.T. and HULKA, B.S., Screening mammography in the elderly: a case-control study. J. gen. int. Med., 3, 126-131 (1988).
4. CAMPBELL, M.K., FEUER, E.J. and WUN, L.-M, Cohort-specific risks of developing breast cancer to age 85 in Connecticut. Epidemiology, 5, 290-296 (1994).
5. CHEN, H.-H., TABÁR, L., FAGERBERG, G. and DUFFY, S.W., Effect of breast cancer screening after age 65. J. med. Screening, 2, 10-14 (1995).
6. CLARK, G.M., OSBORNE, C.K. and MCGUIRE, W.L., Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer. J. clin. Oncol., 2, 1102-1109 (1984).
7. COSTANZA, M.E., ANNAS, G.J., BROWN, M.L., CASSEL, C.K., CHAMPION, C., COHEN, H.J., FRAME, P.S., GLASSE, L., MOR, V. and PAUKER, S.G., Supporting statements and rationale. J. Gerontol., 47, 7-16 (1992).
8. DE KONING, H.J., BOER, R., WARMERDAM, P.G., BEEMSTERBOER, P.M.M. and VAN DER MAAS, P.J., Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials. J. nat. Cancer Inst., 87, 1217-1223 (1995).
9. FLETCHER, S.W., BLACK, W., HARRIS, R., RIMER, B.K. and SRAPIRO, S., Report of the International Workshop on screening for breast cancer. J. nat. Cancer Inst., 85, 1644-1656 (1993).
10. HARRIS, J.R., LIPPMAN, M.E., VERONESI, U. and WILLETT, W., Breast cancer (first of three parts). N. Engl. J Med., 327, 319-328 (1992).
11. HURLEY, S.F. and KALDOR, J.M., The benefits and risks of mammographic screening for breast cancer. Epidemiol. Rev., 14, 101-130 (1992).
12. LINDGREN, A., Autopsy and cause of death in randomized mammography studies. Qual. Ass. Health Care. 5, 303-307 (1993).
13. MIETTINEN, O.S., Estimability and estimation in case-referent studies. Amer. J. Epidemiol. 103, 226-235 (1976).
14. MORRISON, A.S., Efficacy of screening for breast cancer in older women. J. Gerontol., 47, 80-84 (1992).
15. MORRISON, A.S., BRISSON, J. and KHALID, N., Breast cancer incidence and mortality in the Breast Cancer Detection Demonstration Project [published errata appear in J. nat. Cancer Inst., 81, 1513 (1989)]. J. nat. Cancer Inst., 80, 1540-1547 (1988).
16. NATIONAL EVALUATION TEAM FOR BREAST CANCER SCREENING (NETB), Nation-wide breast cancer screening in the Netherlands: support for breast-cancer mortality reduction. Int. J. Cancer, 60, 777-780 (1995).
17. NYSTRÖM, L., RUTQVIST, L.E., WALL, S., LINDGREN, A., LINOVIST, M., RYDÉN. S., ANDERSSON, I., BJURSTAM, N., FAGERBERG, G., FRISELL, J., TABÁR, L. and LARSSON, L.-G., Breast cancer screening with mammography: overview of Swedish randomised trials [published erratum appears in Lancet, 342,1372 (1993)]. Lancet, 341, 973-978 (1993).
18. OTTEN, J.D.M., VAN DijCK, J.A.A.M., PEER. P.G.M., STRAATMAN, H., VERBEEK, A.L.M., MRAVUNAC, M., HENDRIKS, J.H.C.L. and HOLLAND, R., Long-term breast cancer screening in Nijmegen: the 9 rounds from 1975-1992. J. Epidemiol. Comm. Health (1996) (in press).
19. PEER, P.G.M., HOLLAND, R., HENDRIKS, J.H.C.L., MRAVUNAC, M. and VERBEEK, A.L.M., Age-specific effectiveness of the Nijmegen population-based breast cancer-screening program: assessment of early indicators of screening effectiveness. J. nat. Cancer Inst., 86, 436-441 (1994).
20. PEER, P.G.M., VAN DIJCK, J.A.A.M., HENDRIKS, J.H.C.L., HOLLAND, R. and VERBEEK, A.L.M., Age-dependent growth rate of primary breast cancer. Cancer, 71, 3547-3551 (1993).
21. PEETERS, P.H.M., VERBEEK, A.L.M., ZIELHUIS, G.A., Voous, G.P., HENDRIKS, J.H.C.L. and MRAVUNAC, M., Breast cancer screening in women over age 50: a critical appraisal. Acta. Radiol., 31, 225-231 (1990).
22. RUTQVIST, L.E., MILLER, A.B., ANDERSSON, I., HAKAMA, M., HAKULINEN, T., SIGFÚSSON, B.F. and TABÁR, L., Reduced breast-cancer mortality with mammography screening: an assessment of currently available data. Int. J. Cancer. 5 (Suppl.), 76-84 (1990).
23. SATARIANO, W.A. and RAGLAND, D.R., The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann. int. Med., 120, 104-110 (1994).
24. SCHULTEN, L.J., STRAATMAN, H., KIEMENEY, L.A.L.M. and VERBEEK, A.L.M., Cancer incidence: life table risk versus cumulative risk. J Epidemiol. Comm. Health, 48, 596-600 (1994).
25. SHAPIRO, S., Periodic breast cancer screening in seven foreign countries. Cancer, 69, 1919-1924 (1992).
26. TABÁR, L., FAGERBERG, G., CHEN, H.-H., DUFFY, S.W., SMART, C.R., GAD, A.G. and SMITH, R.A., Efficacy of breast cancer screening by age: new results from the Swedish two-county trial Cancer, 75, 2507-2517 (1995).
27. VAN DIJCK, J.A.A.M., HOLLAND, R., VERBEEK, A.L.M., HENDRIKS, J.H.C.L. and MRAVUNAC, M., Efficacy of mammographic screening of the elderly: a case-referent study in the Nijmegen program in the Netherlands. J. nat. Cancer Inst., 86, 934-938 (1994).
28. VERBEEK, A.L.M., HENDRIKS, J.H.C.L., HOLLAND, R., MRAVUNAC, M. and STURMANS, F., Mammographic screening and breast cancer mortality: age-specific effects in the Nijmegen project, 1975-1982. Lancet. I, 865-866 (1985).
29. VERBEEK, A.L.M., HENDRIKS, J.H.C.L., HOLLAND, R., MRAVUNAC, M., STURMANS, F. and DAY, N.E., Reduction of breast cancer mortality through mass screening with modern mammography: first results of the Nijmegen Project. 1975-1981. Lancet, I, 1222-1224 (1984).
30. WEGMAN, M.E., Annual summary of vital statistics - 1993. Pediatrics, 92, 743-754 (1993).
31. WOODMAN, C.B.J., THREFALL, A.G., BOOGIS, C.R.M. and PRIOR, P., Is the three year screening interval too long? Occurrence of interval cancers in NHS breast screening programme's north western region. Brit. med. J., 310, 224-226 (1995)
32. YANCIK, R., RIES, L.G. and YATES, J.W., Breast cancer in aging women: a population-based study of contrasts in stage, surgery, and survival. Cancer, 63, 976-981 (1989).